Scientific Data

Label Guarantee

100 Billion CFU per gram

Maximum Concentration

150-200 Billion CFU per gram

Growth

Anaerobic

Viable (Optimal) pH Range

(5.0 to 5.7)

Viable (Optimal) Temp. Range

(around 37°C)

Metabolites Produced

Lactic acid

Resources Utilized

L-Arabinose, D-Fructose, D-Galactosamine, D-Galactose, D-Lactose, Melibiose, Raffinose, D-Ribose, Salicin, Starch, Sucrose, and D-Xylose

The information contained in this documentation is true and accurate to the best of MicroSynergies® knowledge. Recommendations made are to be used as guidelines only and are accepted at the user’s risk; user must investigate and establish the suitability of all recommendations under user’s actual conditions.

Availability: In-Production/In-Stock

Organism Overview

Bifidobacterium animalis ssp. animalis is an anaerobic member of the LAB (lactic acid bacteria) family and is classified commercially as a probiotic.

This organism is found in the digestive tract of many mammals including humans, dogs, and calves – and

is plentifully found in newborn mammals when various Bifidobacteria are acquired by the newborn from its mother.

In various laboratory studies, B. animalis has been shown to exhibit clinically relevant traits including immune modulation, epithelial adherence (the membrane-like substance made of cells that surrounds internal organs), and enhancement of gut barrier function.

Available Strains

• MicroChoice® Bifidobacterium animalis ssp. lactis BiAL-pAW™

• Bifidobacterium animalis ssp. lactis BiAL-UiW™

Additional Strain Information

• Non-GMO Project Verified

• cGMP

• NSF

Approved Use

Grade

• Human

• Livestock

• Companion Animals

Commercial Application

• Direct-Fed Microbials (calves)

• Companion Animals (dogs, cats, and equine)

• Functional Foods

• Human Supplements

• Human Therapeutics

• Zoological

Market Access

• USDA

• AAFCO

• U.S. FDA

• QPS (Europe: EU/EEA)

• EFSA (Europe: EU/EEA)

• Health Canada for Human and Verinary Use

• Others